-
Signature
-
/s/ Richard Steinhart, as Attorney in Fact for Vimal Mehta, Ph.D.
-
Stock symbol
-
BTAI
-
Transactions as of
-
Mar 14, 2024
-
Transactions value $
-
-$13,823
-
Form type
-
4
-
Date filed
-
4/8/2024, 07:32 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
BTAI |
Common Stock |
Options Exercise |
|
+2.61K |
+8.1% |
|
34.8K |
Mar 14, 2024 |
Direct |
F1 |
transaction |
BTAI |
Common Stock |
Options Exercise |
|
+14K |
+40.19% |
|
48.8K |
Mar 15, 2024 |
Direct |
F1 |
transaction |
BTAI |
Common Stock |
Sale |
-$2.17K |
-829 |
-1.7% |
$2.62 |
48K |
Apr 4, 2024 |
Direct |
F2 |
transaction |
BTAI |
Common Stock |
Sale |
-$11.7K |
-4.44K |
-9.25% |
$2.62 |
43.6K |
Apr 4, 2024 |
Direct |
F2, F3 |
holding |
BTAI |
Common Stock |
|
|
|
|
|
2K |
Mar 14, 2024 |
By spouse |
|
holding |
BTAI |
Common Stock |
|
|
|
|
|
8.55M |
Mar 14, 2024 |
By BioXcel LLC |
F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
BTAI |
Restricted Stock Units |
Options Exercise |
$0 |
-2.61K |
-11.11% |
$0.00 |
20.9K |
Mar 14, 2024 |
Common Stock |
2.61K |
|
Direct |
F1, F5 |
transaction |
BTAI |
Restricted Stock Units |
Options Exercise |
$0 |
-14K |
-25% |
$0.00 |
42K |
Mar 15, 2024 |
Common Stock |
14K |
|
Direct |
F1, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: